CADONILIMAB

Clinical trials for CADONILIMAB explained in plain language.

Never miss a new study

Get alerted when new CADONILIMAB trials appear

Sign up with your email to follow new studies for CADONILIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Drug combo shrinks tumors, saves kidneys in High-Risk cancer

Disease control Completed

This study tested whether giving two drugs, cadonilimab and lenvatinib, before surgery could shrink high-risk kidney tumors enough to allow for a kidney-sparing operation. It involved 39 patients with localized kidney cancer for whom surgery was difficult. The goal was to see if …

Matched conditions: CADONILIMAB

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

CADONILIMAB

Get alerted when new CADONILIMAB trials appear

Drug combo shrinks tumors, saves kidneys in High-Risk cancer